Eric Sijbrands

14PUBLICATIONS
56CO-AUTHORS
Neurology and neuromuscular diseasesCancer geneticsMolecular targetsCardiology (incl. cardiovascular diseases)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 17, 2026
IgG N-Glycosylation and Incident Neuropathy and Nephropathy in People With Type 2 Diabetes: A Pooled Analysis of Prospective Cohort Studies.

|Jul 16, 2025
From In Vitro Efficacy to Long-Term HbA1c Response for GLP-1R/GlucagonR Agonism Using the 4GI-HbA1c Systems Model.

Rolien Bosch, Marcella Petrone, Rosalin Arends

|Jun 13, 2024
Quantification of the effect of GLP-1R agonists on body weight using in vitro efficacy information: An extension of the Hall body composition model.

Rolien Bosch, Eric J G Sijbrands, Nelleke Snelder

|May 25, 2024
Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes.

Annemieke Naber, Daniel Demus, Roderick C Slieker

|Aug 17, 2023
Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease.

Alexander S F Berry, Laney K Jones, Eric J Sijbrands

|Jul 09, 2023
IgG N-glycans are associated with prevalent and incident complications of type 2 diabetes.

Elham Memarian, Ralph Heijmans, Roderick C Slieker

Pageof 3

Frequent Collaborators

3 joint publications

Roderick C Slieker

2 joint publications

Behiye Özcan

2 joint publications

Nelleke Snelder

2 joint publications

Rolien Bosch